Francesco Mannelli

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Topics

Acute Myeloid Leukemia

Cardiovascular Risk Factors

Multiple Myeloma

Top Venues

American journal of hematology

Blood cancer journal

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Giuseppe Gaetano Loscocco, Francesca Gesullo, Giulio Capecchi, Alessandro Atanasio, Chiara Maccari, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood cancer journal 14 (1) (2024)
Paola Guglielmelli, Barbara Mora, Francesca Gesullo, Francesco Mannelli, Giuseppe Gaetano Loscocco, Leonardo Signori, Chiara Pessina, Ilaria Colugnat, Raffaela Aquila, Manjola Balliu, Chiara Maccari, Simone Romagnoli, Chiara Paoli, Elena Nacca, Lorenzo Fagiolo, Margherita Maffioli, Tiziano Barbui, Francesco Passamonti, Alessandro Maria Maria Vannucchi
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia. American journal of hematology 99 (8) (2024)
Laura Calabresi, Chiara Carretta, Simone Romagnoli, Giada Rotunno, Sandra Parenti, Matteo Bertesi, Bartalucci Niccolò, Sebastiano Rontauroli, Chiara Chiereghin, Sara Castellano, Giulia Gentili, Chiara Maccari, Fiorenza Vanderwert, Francesco Mannelli, Matteo Della Porta, Rossella Manfredini, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms. American journal of hematology (2023)
Giuseppe Gaetano Loscocco, Stefano Ascani, Francesco Mannelli, Magda Zanelli, Giada Rotunno, Raffaella Santi, Alessandro Maria Maria Vannucchi
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement. American journal of hematology (2023)
Giuseppe Gaetano Loscocco, Giada Rotunno, Francesco Mannelli, Giacomo Coltro, Francesca Gesullo, Fabiana Pancani, Leonardo Signori, Chiara Maccari, Maria Esposito, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis. American journal of hematology (2023)
Ayalew Tefferi, Giuseppe Gaetano Loscocco, Faiqa Farrukh, Natasha Szuber, Francesco Mannelli, Animesh D Pardanani, Curtis A Hanson, Rhett P Ketterling, Valerio De Stefano, Alessandra Carobbio, Tiziano Barbui, Paola Guglielmelli, Naseema Gangat, Alessandro Maria Maria Vannucchi
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count. American journal of hematology (2023)
Matteo Piccini, Francesco Mannelli, Giacomo Coltro
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions. Bioengineering (Basel, Switzerland) 10 (5) (2023)
Francesco Mannelli, Paola Guglielmelli, Paola Fazi, Enrico Crea, Alfonso Piciocchi, Marco Vignetti, Sergio Amadori, Fabrizio Pane, Adriano Venditti, Alessandro M Vannucchi
ENABLE: treatment combination including decitabine and venetoclax in acute myeloid leukemia secondary to myeloproliferative neoplasms. Future oncology (London, England) (2023)
Francesco Mannelli, Francesca Crupi, Roberta Zanotti, Livio Pagano, Davide Rapezzi, Ilaria Tanasi, Marianna Criscuolo, Massimiliano Bonifacio, Alberto Fresa, Paola Guglielmelli, Alessandro M Vannucchi
The clinical experience of compassionate use program for avapritinib: implications for drug positioning in the therapeutic scenario of systemic mastocytosis. Therapeutic advances in hematology 14 (2023)
Giuseppe Gaetano Loscocco, Raffaella Santi, Valentina Carrai, Giacomo Coltro, Francesco Mannelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis. International journal of laboratory hematology 44 (6) (2022)
Giacomo Coltro, Francesco Mannelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Giada Rotunno, Chiara Maccari, Fabiana Pancani, Alessandro Atanasio, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Differential prognostic impact of cytopenic phenotype in prefibrotic vs overt primary myelofibrosis. Blood cancer journal 12 (8) (2022)
Paola Guglielmelli, Giacomo Coltro, Francesco Mannelli, Giada Rotunno, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Chiara Maccari, Chiara Paoli, Simone Romagnoli, Bartalucci Niccolò, Alessandro Maria Maria Vannucchi
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera. Blood advances 6 (9) (2022)
Francesco Mannelli, Sara Bencini, Giacomo Coltro, Giuseppe Gaetano Loscocco, Benedetta Peruzzi, Giada Rotunno, Chiara Maccari, Francesca Gesullo, Miriam Borella, Chiara Paoli, Roberto Caporale, Carmela Mannarelli, Francesco Annunziato, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis. American journal of hematology 97 (7) (2022)
Francesco Mannelli, Francesca Gesullo, Carmela Mannarelli, Fiorenza Vanderwert, Stefano Lazzi, Francesco Mungai, Valentina Berti, Raffaella Santi, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Diagnostic and therapeutic challenges in mast cell sarcoma. American journal of hematology (2022)
Francesca Crupi, Benedetta Sordi, Fiorenza Vanderwert, Francesca Gesullo, Andrea Amorosi, Francesco Mannelli, Raffaella Santi
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management. International journal of molecular sciences 23 (15) (2022)
Giuseppe Gaetano Loscocco, Paola Guglielmelli, Francesco Mannelli, Barbara Mora, Carmela Mannarelli, Giada Rotunno, Fabiana Pancani, Chiara Maccari, Bartalucci Niccolò, Simone Romagnoli, Giacomo Coltro, Francesco Passamonti, Alessandro Maria Maria Vannucchi
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates. American journal of hematology 97 (9) (2022)
Francesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, Francesco Buccisano, Roberto Caporale, Marco Chiarini, Giuseppe Rossi, Adriano Venditti, Paola Fazi, Enrico Crea, Alfonso Piciocchi, Maria Teresa Voso, Marco Vignetti, Sergio Amadori, Alessandro Maria Vannucchi
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trial. Future oncology (London, England) 17 (29) (2021)
Giuseppe Gaetano Loscocco, Elisabetta Antonioli, Ilaria Romano, Federica Vergoni, Giada Rotunno, Francesco Mannelli, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis. American journal of hematology 96 (6) (2021)
Francesco Mannelli
Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease. Journal of clinical medicine 10 (3) (2021)
Paola Guglielmelli, Giuseppe Gaetano Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo, Giacomo Coltro, Silvia Betti, Chiara Maccari, Sara Ceglie, Patrizia Chiusolo, Chiara Paoli, Tiziano Barbui, Ayalew Tefferi, Valerio De Stefano, Alessandro Maria Maria Vannucchi
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis. Blood cancer journal 11 (12) (2021)
Paola Guglielmelli, Arianna Ghirardi, Alessandra Carobbio, Arianna Masciulli, Chiara Maccari, Barbara Mora, Elisa Rumi, Ana Triguero, Maria Chiara Finazzi, Helna Pettersson, Chiara Paoli, Francesco Mannelli, Daniele Vanni, Alessandro Rambaldi, Francesco Passamonti, Alberto Alvarez-Larran, Bjorn I Andreasson, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of ERNEST Study. Blood advances (2021)
Naseema Gangat, Paola Guglielmelli, Natasha Szuber, Kebede H Begna, Mirinal S Patnaik, Mark R Litzow, Aref Al-Kali, James M Foran, Jeanne M Palmer, Hassan Alkhateeb, Michelle A Elliott, Curtis A Hanson, Animesh D Pardanani, Francesco Mannelli, Alessandro Maria Maria Vannucchi, Ayalew Tefferi
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases. American journal of hematology 96 (7) (2021)
Francesco Mannelli, Sara Bencini, Matteo Piccini, Giacomo Gianfaldoni, Maria Ida Bonetti, Benedetta Peruzzi, Roberto Caporale, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Leonardo Signori, Michela Zizza, Francesco Annunziato, Alberto Bosi
Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category. Cancers 12 (11) (2020)
Francesco Mannelli, Giacomo Gianfaldoni, Sara Bencini, Matteo Piccini, Ilaria Cutini, Maria Ida Bonetti, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Marco Chiarini, Erika Borlenghi, Renato Bassan, Giuseppe Rossi, Alberto Bosi
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia. American journal of hematology 95 (11) (2020)
Francesco Mannelli
Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis. Annals of hematology 100 (2) (2020)
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, Valerio De Stefano, Lara Mannelli, Francesco Mannelli, Giada Rotunno, Giacomo Coltro, Silvia Betti, Chiara Cavalloni, Maria Chiara Finazzi, Juergen Thiele, Mario Cazzola, Alessandro Maria Maria Vannucchi, Tiziano Barbui
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis. Blood cancer journal 10 (2) (2020)
Giada Rotunno, Carmela Mannarelli, Giada Brogi, Annalisa Pacilli, Francesca Gesullo, Francesco Mannelli, Sara Fiaccabrino, Benedetta Sordi, Chiara Paoli, Ilaria Marone, Elisa Rumi, Rossella Manfredini, Giovanni Barosi, Mario Cazzola, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation. Blood 133 (26) (2019)
Francesco Mannelli, Francesca Gesullo, Giada Rotunno, Annalisa Pacilli, Lisa Pieri, Paola Guglielmelli, Alessandro Maria Maria Vannucchi
Validation of the Mayo alliance prognostic system for mastocytosis. Blood cancer journal 9 (2) (2019)
Annalisa Pacilli, Giada Rotunno, Carmela Mannarelli, Tiziana Fanelli, Alessandro Pancrazzi, Elisa Contini, Francesco Mannelli, Francesca Gesullo, Bartalucci Niccolò, Giuditta Corbizi Fattori, Chiara Paoli, Alessandro Maria Maria Vannucchi, Paola Guglielmelli
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea. Blood cancer journal 8 (12) (2018)